All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
CELG / Celgene Corp.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
AKRX / Akorn, Inc.
|
|
|
|
|
|
|
|
ENDP / Endo International plc
|
|
|
|
|
|
|
|
SPNC / Spectranetics Corp. (The)
|
|
|
|
|
|
|
|
CPHD / Cepheid
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CYH / Community Health Systems, Inc.
|
|
|
|
|
|
|
|
BIO / Bio-Rad Laboratories, Inc.
|
|
|
|
|
|
|
|
ENTL / Entellus Medical, Inc.
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
/ Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
MYGN / Myriad Genetics, Inc.
|
|
|
|
|
|
|
|
KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
STRM / Streamline Health Solutions, Inc.
|
|
|
|
|
|
|
|
878193101 / TearLab Corp
|
|
|
|
|
|
|
|
ANGO / AngioDynamics, Inc.
|
|
|
|
|
|
|
|
US29266S3040 / Endologix, Inc.
|
|
|
|
|
|
|
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
HBIO / Harvard Bioscience, Inc.
|
|
|
|
|
|
|
|
CYNA / Cynapsus Therapeutics Inc.
|
|
|
|
|
|
|
|
US74975N1054 / RTI Surgical, Inc.
|
|
|
|
|
|
|
|
LMAT / LeMaitre Vascular, Inc.
|
|
|
|
|
|
|
|
HSTM / HealthStream, Inc.
|
|
|
|
|
|
|
|
449575AB5 / Igi Laboratories Inc Bond
|
|
|
|
|
|
|
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PETX / Aratana Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARROWHEAD RESH CORP
/ CS (042797209) |
|
|
|
|
|
|
|
DOC / Healthpeak Properties, Inc.
|
|
|
|
|
|
|
|
AET / Aetna, Inc.
|
|
|
|
|
|
|
|
018490100 / Allergan plc
|
|
|
|
|
|
|
|
STKL / SunOpta Inc.
|
|
|
|
|
|
|
|
AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
FLDM / Standard BioTools Inc
|
|
|
|
|
|
|
|
STE / STERIS plc
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
STJ / St. Jude Medical, Inc.
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
US00C4U1L353 / Mylan N.V.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
LHCG / LHC Group Inc
|
|
|
|
|
|
|
|
PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
BDX / Becton, Dickinson and Company
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
SNY / Sanofi - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ESPR / Esperion Therapeutics, Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
TECH / Bio-Techne Corporation
|
|
|
|
|
|
|
|
JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
HUM / Humana Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
ENZ / Enzo Biochem, Inc.
|
|
|
|
|
|
|
|
ELV / Elevance Health, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
NVS / Novartis AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
NEO / NeoGenomics, Inc.
|
|
|
|
|
|
|
|
MDCO / Medicines Company
|
|
|
|
|
|
|
|
ATRC / AtriCure, Inc.
|
|
|
|
|
|
|
|
OMCL / Omnicell, Inc.
|
|
|
|
|
|
|
|